Dr Melanie Formica

Clinical Psychologist

Dr Melanie (Mel) Formica (she/her) is a Clinical Psychologist who has worked across a variety of community and hospital based settings. Mel takes a holistic, person-centred, and neuroaffirming approach to clinical care. She supports her clients to understand the patterns that underlie their challenges, to identify and facilitate areas of growth without judgement. Mel aims to bring her values of transparency, reliability, and authenticity to every session to aid in building strong therapeutic relationships.

Experience working with:

Mel has extensive experience working with people with eating disorders and complex trauma across the lifespan. She supports a wide-range of neurodiverse people as well as those from the LGBTQIA+ community and marginalised backgrounds. Mel uses several evidence-based therapeutic modalities with her clients, including Specialist Supportive Clinical Management (SSCM), Temperment Based Therapy with Supports (TBT-S), Family Based Treatment (FBT), Cognitive Behavioural Therapy, and Schema Therapy.

Deakin University
Doctor of Psychology (Clinical)
University of Melbourne
Bachelor of Arts (Honours)

2020
Automated Analysis of Responses on Verbal Fluency Tests in Schizophrenia Risk States
2022
Has improved treatment contributed to the declining rate of transition to psychosis in ultra-high-risk cohorts?
2023
A Sequential Adaptive Intervention Strategy Targeting Remission and Functional Recovery in Young People at Ultrahigh Risk of Psychosis The Staged Treatment in Early Psychosis (STEP) Sequential Multiple Assignment Randomized Trial
2023
Differential Expression of Anomalous Self-Experiences in Spontaneous Speech in Clinical High-Risk and Early-Course Psychosis Quantified by Natural Language Processing
2023
The relationship between subjective sleep disturbance and attenuated psychotic symptoms after accounting for anxiety and depressive symptoms
2023
The SPEAK study rationale and design: A linguistic corpus-based approach to understanding thought disorder
2024
Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis
2024
Associations between disturbed sleep and attenuated psychotic experiences in people at clinical high risk for psychosis
2024
Erythrocyte membrane fatty acid concentrations and myelin integrity in young people at ultra-high risk of psychosis
2024
The self, neuroscience and psychosis study: Testing a neurophenomenological model of the onset of psychosis
2025
Basic Self Disturbance and Clinical Outcome in a large Ultra High Risk for Psychosis (UHR) Prospective Sample
2025
Psychosis and the Self: How Spontaneous Discussions of Subjective Experiences Compare in the Clinical High-Risk and First-Episode Psychosis Populations
2025
Psychosis Risk: Time to Look Empirically at a First-step Economical-pragmatic Way to Examine Anomalous Self-experience. Exploring the SQuEASE-11
2025
The inventory of psychotic-like anomalous self-experiences (IPASE): Stability and relationships with attenuated psychotic symptoms and remission in individuals at-risk for psychosis
2026
Exploring the Relationship Between Inflammatory Biomarkers and Negative Symptoms Subtypes in Individuals at Ultra-High Risk for Psychosis

Book an appointment with Mel

Mel’s fee is $280 per 50-minute session. After hour appointments incur an additional $40 fee.

Need something sooner?

Add your name to our cancellation list, and we’ll contact you if an earlier appointment becomes available.